India to United States: Posaconazole Export Trade Route

The India to United States Posaconazole corridor is one of India's established pharmaceutical export routes, with 47 shipments documented worth a combined $79.1M USD. The route is dominated by AET LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 91% of all export value, reflecting the consolidated nature of India's posaconazole manufacturing sector.

Across 15 active suppliers, the average shipment value stands at $1.7M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with posaconazole's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 28.4%, placing it at rank #19 among India's top posaconazole export destinations globally.

On the import side, key buyers of Indian posaconazole in United States include UPS SUPPLY CHAIN SOLUTIONS, EUGIA US LLC,, DR REDDYS LABORATORIES INC and 19 others. UPS SUPPLY CHAIN SOLUTIONS is the single largest importer with 8 shipments valued at $72.3M USD.

India's posaconazole exports to United States are driven primarily by a handful of large-scale manufacturers. AET LABORATORIES PRIVATE LIMITED with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 15 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AET LABORATORIES PRIVATE LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, HETERO LABS LIMITED — together account for 95% of total trade value on this route. The average shipment value of $1.7M USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as pharma : posaconazole delayed release ta and pharma : posaconazole delayed release tablets 100 mg - 14020x60's commercial document no: 071/23-24 dt. 20.10.2023, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, UPS SUPPLY CHAIN SOLUTIONS is the largest importer with 8 shipments worth $72.3M USD — representing 91% of all posaconazole imports from India on this route. A total of 22 buyers are active on this corridor.